Human IL-1 beta antagonists

Details for Australian Patent Application No. 2004207741 (hide)

Owner Applied Molecular Evolution, Inc.

Inventors Watkins, Jeffry Dean; Vasserot, Alain Philippe; Lu, Jirong; Dickinson, Craig Duane

Agent Spruson & Ferguson

Pub. Number AU-B-2004207741

PCT Pub. Number WO2004/067568

Priority 60/442,798 24.01.03 US

Filing date 21 January 2004

Wipo publication date 12 August 2004

Acceptance publication date 10 February 2011

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

23 June 2005 PCT application entered the National Phase

  PCT publication WO2004/067568 Priority application(s): WO2004/067568

10 February 2011 Application Accepted

  Published as AU-B-2004207741

9 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004207745-Flexible fluid containment vessel featuring a keel-like seam

2004207740-Indole-derivative modulators of steroid hormone nuclear receptors